Rvnc investor alert: kirby mcinerney llp notifies revance therapeutics, inc. investors of upcoming lead plaintiff deadline in class action lawsuit

New york, feb. 04, 2025 (globe newswire) -- the law firm of kirby mcinerney llp reminds investors of the march 4, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired revance therapeutics, inc. (“revance” or the “company”) (nasdaq:rvnc) securities during the period from february 29, 2024, through december 6, 2024 (“the class period”).
RVNC Ratings Summary
RVNC Quant Ranking